Hepatitis-B-Immunglobulin Behring, Injektionslösung

7680006740044 CH-674 Injektionslösung
Hepatitis-B-Immunglobulin Behring, Injektionslösung
Hepatitis-B-Immunglobulin Behring, Injektionslösung
1 / 2
google

Article details

Package size
5
Selling units
5
Measure
ml
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
04/09/2025
Summary of Product Characteristics
Français
04/09/2025
Summary of Product Characteristics
Italien
04/09/2025

Detailed composition

Substance Quantity Type Category
(N/A)
- Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance WIZUS
(N/A)
- Substance RESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Authorization holder

CSL Behring AG

3014 Bern

Authorization information

Swissmedic authorization number
674
Drug name
Hepatitis-B-Immunglobulin Behring, Injektionslösung
Galenic form
LSINJ
ATC Code
J06BB04
Authorization status
Z
Dispensing category
B
First authorization
01/03/2004
Authorization expiration date
31/12/9999
IT Number
08.09.
Domain
Human medicine
Field of application
passive Immunisierung gegen Hepatitis B, ab Geburt

Package details

Description (FR)
HEPATITIS B-IG Behring 1000 UI ser pré 5 ml
Description (DE)
HEPATITIS B-IG Behring 1000 IE Fertspr 5 ml
Market launch
01/03/2004
Narcotic (BTM)
No

Application methods

IMU

Other package sizes (1)

HEPATITIS B-IG Behring 200 UI ser pré
1 ML
GTIN: 7680006740037
View